Source:http://linkedlifedata.com/resource/pubmed/id/11554609
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
2001-9-13
|
pubmed:abstractText |
In vivo assessment of the beta-sheet proteins deposited in amyloid plaques (A beta peptide) or neurofibrillary tangles (tau protein) presents a target for the development of biological markers for Alzheimer's disease (AD). In an effort to develop in vivo beta-sheet imaging probes, derivatives of thioflavin-T (ThT) were synthesized and evaluated. These compounds lack the positively charged quaternary heterocyclic nitrogen of ThT and are therefore uncharged at physiological pH. They are 600-fold more lipophilic than ThT. These ThT derivatives bind to A beta(1-40) fibrils with higher affinity (Ki = 20.2 nM) than ThT (Ki = 890 nM). The uncharged ThT derivatives stained both plaques and neurofibrillary tangles in post-mortem AD brain, showing some preference for plaque staining. A carbon-11 labeled compound, [N-methyl-11C]6-Me-BTA-1, was prepared, and its brain entry and clearance were studied in Swiss-Webster mice. This compound entered the brain at levels comparable to commonly used neuroreceptor imaging agents (0.223 %ID-kg/g or 7.61 %ID/g at 2 min post-injection) and showed good clearance of free and non-specifically bound radioactivity in normal rodent brain tissue (brain clearance t(1,2) = 20 min). The combination of relatively high affinity for amyloid, specificity for staining plaques and neurofibrillary tangles in post-mortem AD brain, and good brain entry and clearance makes [N-methyl-11C]6-Me-BTA-1 a promising candidate as an in vivo positron emission tomography (PET) beta-sheet imaging agent.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0024-3205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1471-84
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:11554609-Alzheimer Disease,
pubmed-meshheading:11554609-Amyloid beta-Peptides,
pubmed-meshheading:11554609-Animals,
pubmed-meshheading:11554609-Brain,
pubmed-meshheading:11554609-Chemistry, Physical,
pubmed-meshheading:11554609-Female,
pubmed-meshheading:11554609-Fluorescent Dyes,
pubmed-meshheading:11554609-Histocytochemistry,
pubmed-meshheading:11554609-Hydrogen-Ion Concentration,
pubmed-meshheading:11554609-Mice,
pubmed-meshheading:11554609-Physicochemical Phenomena,
pubmed-meshheading:11554609-Protein Binding,
pubmed-meshheading:11554609-Solubility,
pubmed-meshheading:11554609-Spectrometry, Fluorescence,
pubmed-meshheading:11554609-Thiazoles,
pubmed-meshheading:11554609-Tomography, Emission-Computed
|
pubmed:year |
2001
|
pubmed:articleTitle |
Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain.
|
pubmed:affiliation |
Department of Psychiatry, University of Pittsburgh School of Medicine, PA 15213, USA. Klunkwe@msx.upmc.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|